Influence of sodium nitroprusside on expressions of FBXL5 and IRP2 in SH-SY5Y cells.
- Author:
Jie WEI
1
;
Yong LI
1
;
Qian JIAO
1
;
Xi-Xun DU
1
;
Hong JIANG
2
Author Information
1. Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Medical College of Qingdao University, Qingdao 266071, China.
2. Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Medical College of Qingdao University, Qingdao 266071, China. hongjiang@qdu.edu.cn.
- Publication Type:Journal Article
- MeSH:
Cell Line;
Cell Survival;
F-Box Proteins;
metabolism;
Homeostasis;
Humans;
Iron Regulatory Protein 2;
metabolism;
Nitric Oxide;
metabolism;
Nitroprusside;
pharmacology;
Proteasome Endopeptidase Complex;
Ubiquitin;
metabolism;
Ubiquitin-Protein Ligase Complexes;
metabolism
- From:
Acta Physiologica Sinica
2017;69(3):261-266
- CountryChina
- Language:English
-
Abstract:
Iron accumulation in the brain is associated with the pathogenesis of Parkinson's disease (PD). Misexpression of some iron transport and storage proteins is related to iron dyshomeostasis. Iron regulatory proteins (IRPs) including IRP1 and IRP2 are cytosolic proteins that play important roles in maintaining cellular iron homeostasis. F-box and leucine-rich repeat protein 5 (FBXL5) is involved in the regulation of iron metabolism by degrading IRP2 through the ubiquitin-proteasome system. Nitric oxide (NO) enhances the binding activity of IRP1, but its effect on IRP2 is ambiguous. Therefore, in the present study, we aim to determine whether sodium nitroprusside (SNP), a NO donor, regulates FBXL5 and IRP2 expression in cultured SH-SY5Y cells. MTT assay revealed that treatment of SNP attenuated the cell viability in a dose-dependent manner. Flow cytometry test showed that 100 and 300 μmol/L SNP administration significantly reduced the mitochondrial membrane potential by 45% and 60%, respectively. Moreover, Western blotting analysis demonstrated that 300 μmol/L SNP significantly increased FBXL5 expression by about 39%, whereas the expression of IRP2 was decreased by 46%, correspondingly. These findings provide evidence that SNP could induce mitochondrial dysfunction, enhance FBXL5 expression and decrease IRP2 expression in SH-SY5Y cells.
